Health Condition 1: I260- Pulmonary embolism with acute corpulmonale
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Adult patient with age 18 years and above Patients who are willing to participate in the study by signing informed consent
Exclusion criteria
Exclusion criteria: Un-cooperative patients Patient with High creatinine value
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volumetric Computed Tomography Dose Index and Dose Length Product are the DRL quantities suggested by the guidelines. Effective Dose will be calculated by multiplying Dose length product with the region specific conversion factor. The diagnostic reference level value obtained in this study can be used to establish National diagnostic reference levels.Timepoint: 12 months (Feb 2025 to Feb 2026) | — |
Secondary
| Measure | Time frame |
|---|---|
| Image quality Analysis and typical value to establish diagnostic reference levelTimepoint: 12 months (Feb 2025 to Feb 2026) | — |
Countries
India
Contacts
Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal